Sychedelic, a wearable technology startup based in Delhi NCR, has secured $3.5 million (approximately ₹31.5 crore) in seed funding from a group of investors including Cultadvisors LLP, TurboStart, Ideabaaz, and Praveek Ventures. This funding round also saw participation from several angel investors. The company plans to use the capital to enhance marketing efforts, scale up manufacturing, expand research capabilities, and support the global Kickstarter launch of its innovative AI-powered mental wellness headphones, scheduled for June 2026.
### Sychedelic’s Product and Technology
Originally founded in 2020 as Neuphony by Ria Rustagi and Bhavya Madan, Sychedelic has evolved from developing EEG-based neurofeedback headbands to creating advanced headphones designed to reduce stress and improve mental wellness. The headphones leverage cutting-edge technologies such as photoplethysmography (PPG), adaptive audio systems, and transcranial direct current stimulation (tDCS). These features allow the device to monitor stress levels and cognitive states in real time, offering interventions to enhance focus and support sleep. With operations spanning India and the US, and a science advisor located in New York, Sychedelic is positioning itself as a global player in the neurotechnology space.
### Market Context and Competition
The wearable health technology sector in India is experiencing rapid growth, spurred by a shift from basic fitness tracking devices to complex, mental wellness-focused gadgets. Indian consumers are increasingly embracing products that optimize mental health, sleep, and overall well-being. This is reflected in the rising interest in neurotechnology and biofeedback-based wearables. Sychedelic faces competition from startups like Sputnik Brain, Mave Health, and Dusq, which are also investing in similar technologies. Mave Health, for example, raised $2.1 million earlier this year to fund its own mental health-focused wearable headset, highlighting the competitive landscape Sychedelic is navigating.
### Implications for India’s Startup Ecosystem
Sychedelic’s funding success underscores the growing investor interest in India’s health technology sector, particularly in startups that leverage advanced technologies for mental wellness. The wearable market’s expansion into neurotechnology is opening new opportunities for innovation and investment. Startups in this space are well-positioned to cater to a burgeoning demand for mental health solutions, emphasizing the importance of technology in addressing contemporary wellness challenges. The approval from India’s Central Drugs Standard Control Organisation (CDSCO) and global patent filings further strengthen Sychedelic’s position, potentially setting a precedent for other Indian startups pursuing similar paths.
Looking ahead, Sychedelic’s trajectory will be closely watched by investors and entrepreneurs alike, as it prepares for its Kickstarter launch and scales its operations. For founders and investors, the company’s progress may offer insights into the viability and consumer acceptance of advanced neurotechnology solutions in both domestic and international markets. As the wearable technology landscape continues to evolve, the success of Sychedelic’s global rollout could signal a pivotal moment for India’s healthtech startups, paving the way for further innovation and investment in this promising sector.
